PTEN and PTEN hamartoma tumor syndrome: To study the role of endogenously expressed PTEN-R173C in PHTS, we created heterozygous germline PtenR173C knock-in mice (Pten+/R173C) by CRISPR-Cas9 technology (Fig. S6).